SGEN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SGEN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Seagen's enterprise value is $42,031 Mil. Seagen's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $2,300 Mil. Therefore, Seagen's EV-to-Revenue for today is 18.27.
The historical rank and industry rank for Seagen's EV-to-Revenue or its related term are showing as below:
During the past 13 years, the highest EV-to-Revenue of Seagen was 16.65. The lowest was 13.31. And the median was 16.34.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
As of today (2024-05-16), Seagen's stock price is $228.74. Seagen's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $12.29. Therefore, Seagen's PS Ratio for today is 18.62.
The historical data trend for Seagen's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Seagen Annual Data | |||||||||||||||||||||
Trend | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | |||||||||||
EV-to-Revenue | Get a 7-Day Free Trial | 13.24 | 20.64 | 13.42 | 16.67 | 13.65 |
Seagen Quarterly Data | ||||||||||||||||||||
Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
EV-to-Revenue | Get a 7-Day Free Trial | 13.71 | 13.65 | 13.34 | 16.66 | 16.38 |
For the Biotechnology subindustry, Seagen's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Seagen's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Seagen's EV-to-Revenue falls into.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
Seagen's EV-to-Revenue for today is calculated as:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 42031.201 | / | 2300.351 | |
= | 18.27 |
Seagen's current Enterprise Value is $42,031 Mil.
Seagen's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,300 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Seagen (NAS:SGEN) EV-to-Revenue Explanation
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
Seagen's PS Ratiofor today is calculated as:
PS Ratio | = | Share Price (Today) | / | Revenue per Share (TTM) |
= | 228.74 | / | 12.286 | |
= | 18.62 |
Seagen's share price for today is $228.74.
Seagen's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.29.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Seagen's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
David R Epstein | director, officer: Chief Executive Officer | INTERNATIONAL FLAVORS & FRAGRANCES INC., 521 W. 57TH STREET, NEW YORK NY 10019 |
Vaughn B Himes | officer: See Remarks | C/O SEATTLE GENETICS, INC., 21823 30TH DRIVE SE, BOTHELL WA 98021 |
Charles R Romp | officer: EVP, Commercial | 21823 30TH DRIVE SE, BOTHELL WA 98021 |
Roger D Dansey | officer: See Remarks | 21823 30TH DRIVE SE, BOTHELL WA 98021 |
Jean I Liu | officer: GC & EVP, Legal Affairs | 21823 30TH DRIVE SE, BOTHELL WA 98021 |
Todd E Simpson | officer: Chief Financial Officer | |
Daniel G Welch | director | 4611 UNIVERSITY DR, 4 UNIVERSITY PLACE, DURHAM NC 27707 |
David W Gryska | director | 749 N MARY AVE, SUNNYVALE CA 94085 |
Sandra M Swain | director | 21823 30TH DRIVE SE, BOTHELL WA 98021 |
Ted W Love | director | C/O GLOBAL BLOOD THERAPEUTICS, INC., 400 EAST JAMIE COURT, SUITE 101, SOUTH SAN FRANCISCO CA 94080 |
Clay B Siegall | director, officer: President and CEO | 21823 30TH DR SE, BOTHELL WA 98021 |
Baker Bros. Advisors Lp | director, 10 percent owner | 860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014 |
Felix Baker | director, 10 percent owner | BAKER BROS. ADVISORS LP, 860 WASHINGTON STREET 3RD FLOOR, NEW YORK NY 10014 |
Julian Baker | director, 10 percent owner | BAKER BROS. ADVISORS LP, 860 WASHINGTON STREET 3RD FLOOR, NEW YORK NY 10014 |
Baker Brothers Life Sciences Lp | director, 10 percent owner | 860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014 |
From GuruFocus
By Business Wire Business Wire • 04-26-2023
By GuruFocus Research • 11-01-2023
By GuruFocus Research GuruFocus Editor • 05-19-2023
By Business Wire Business Wire • 04-25-2023
By sperokesalga sperokesalga • 04-25-2023
By sperokesalga sperokesalga • 03-19-2023
By Business Wire • 10-22-2023
By Business Wire • 09-04-2023
By Business Wire • 11-30-2023
By sperokesalga sperokesalga • 03-19-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.